Thank you, Mr. Chair.
Again, I respect Mr. Angus's and all committee members' interventions when I am speaking.
Thank you for pointing out page 1059.
Mr. Angus, I'm trying to come up to speed on all procedural mechanisms and the procedures in place to respect because many of us today are back home in our ridings. We are not in our committee room, though I'll be back in Ottawa next week for the sitting. I'll be in the committee room for the ethics meeting.
We are not in the House of Commons, but we always need to remember to respect the rules and our colleagues. I will try my best to continue to do that and I hope not to stray, and if I do stray, people should point that out, and I'll obviously try to be respectful and understand if I have erred in any sort of manner.
So, Chair, what is clear for us in the motion.... For Mr. Angus, the reason I brought up the grocery business was that they are good corporate citizens and Baylis Medical is a good corporate citizen. That was just an analogy.
As I noted earlier, part of it does deserve some merit, especially as it was carried out in a fair and equitable manner where we study the substance of the issues at hand and do not conduct a fishing expedition.
In looking at the motion at hand, I specifically cite the second paragraph:
that this study continue our work relating to the Canada student service grant, including this committee's work to review the safeguards to prevent conflicts of interest in federal government expenditures; government spending, WE Charity and the Canada student service grant....
I zero in on that section where we talk about government spending.
We talk about what the government has spent in protecting Canadians, and here we are approaching.... Although this week the weather has been strangely mild here in Ontario, I think we are going back to normal temperatures and may have snow next week.
We zero in on the government spending, and we think about what announcements we've made to protect Canadians, and if we finally do get to study the government's spending at this committee, or the COVID-19 app or facial recognition, I ask myself what the government has done to protect Canadians with potential vaccine candidates per se, and we look at those, and we look at this study, and we say that the terms or envelope of the study is okay, and we see what we have done.
Today there is an article in The Economist about how Canada is so uniquely positioned in having come to agreements with a number of entities, organizations and companies for vaccines. For example, we see that we have come to an agreement with AstraZeneca to supply of up to 20 million doses of its viral vaccine candidate AZD1222. Medicago will supply up to 76 million doses of its virus-like particle vaccine candidate, and obviously the Pfizer—